Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-15 4:48 pm Purchase | 13D | IMMUNE THERAPEUTICS INC FLA IMUN | Salomonsky Henry Louis | 12,168,900 14.7% | 12,168,900 (New Position) | View |
| 2021-06-07 07:06 am Purchase | 13D | IMMUNE THERAPEUTICS INC FLA IMUN | Griffin Noreen | 59,877 12.4% | 59,877 (New Position) | View |
| 2020-06-25 8:26 pm Unchanged | 13G | IMMUNE THERAPEUTICS INC FLA IMUN | Ahmetaj Erjon | 22,349 4.88% | 0 (Unchanged) | View |
| 2020-05-18 6:10 pm Sale | 13G | IMMUNE THERAPEUTICS INC FLA IMUN | Iliad Research & Trading L.P. | 45,712 9.99% | -45,466,510 (-99.90%) | View |
| 2019-12-10 08:01 am Purchase | 13G | IMMUNE THERAPEUTICS INC FLA IMUN | Ahmetaj Erjon | 22,349 5% | 22,349 (New Position) | View |
| 2019-05-15 5:32 pm Purchase | 13G | IMMUNE THERAPEUTICS INC FLA IMUN | Iliad Research & Trading L.P. | 45,512,222 9.99% | 6,566,596 (+16.86%) | View |